Verona Pharma plc (VRNA)
Oct 7, 2025 - VRNA was delisted (reason: acquired by MRK)
106.91
+0.12 (0.11%)
Inactive · Last trade price on Oct 6, 2025
Verona Pharma Employees
Verona Pharma had 209 employees as of December 31, 2024. The number of employees increased by 130 or 164.56% compared to the previous year.
Employees
209
Change (1Y)
130
Growth (1Y)
164.56%
Revenue / Employee
$1,060,636
Profits / Employee
-$388,455
Market Cap
9.21B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 209 | 130 | 164.56% |
Dec 31, 2023 | 79 | 43 | 119.44% |
Dec 31, 2022 | 36 | 10 | 38.46% |
Dec 31, 2021 | 26 | -1 | -3.70% |
Dec 31, 2020 | 27 | -6 | -18.18% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
VRNA News
- 2 days ago - Acquisition of Verona by MSD Approved by the High Court of Justice of England and Wales - GlobeNewsWire
- 14 days ago - Shareholders of Verona Pharma Approve Proposed Acquisition by Merck - GlobeNewsWire
- 22 days ago - Verona Pharma to Present Additional Analyses of the Phase 3 ENHANCE Studies in COPD at ERS International Congress 2025 - GlobeNewsWire
- 3 months ago - VERONA PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Verona Pharma plc - VRNA - Business Wire
- 3 months ago - Major deals involving U.S. drugmakers and biotechs over the past decade - Reuters
- 3 months ago - Two big reasons why buying Verona was crucial for Merck - Invezz
- 3 months ago - Merck has struck a roughly $10 billion deal to buy Verona Pharma - WSJ
- 3 months ago - Verona Pharma shares jump with Merck set to acquire company in $10 billion deal - Invezz